INS and metabolic syndrome: The lymphatic angiogenic factor VEGF-C has an integral role in metabolic syndrome-associated adipose tissue inflammation, and blockade of VEGF-C improves systemic insulin sensitivity and protects the liver from high-fat diet-induced steatosis, which is associated with reduced adipocyte size and adipose tissue inflammation [52].